InvestorsHub Logo
Followers 5
Posts 296
Boards Moderated 0
Alias Born 01/18/2012

Re: MR MUTT post# 14028

Thursday, 09/15/2016 5:29:22 PM

Thursday, September 15, 2016 5:29:22 PM

Post# of 64353
I don't know about that - - - I could name a dozen crappy biotech companies that have zero sales, no FDA filings and just an idea for a drug - - and they have market values in the hundreds of millions.

Nutra Pharma's MS drug is real. The fact that the FDA granted them an Orphan Designation is real. I got excited when they announced Dale Vanderputten joining the company - - because he's real.

Sales would be phenomenal and would certainly increase PPS - but any real value would have to be in the speculation of an eventual blockbuster drug (i.e. MS, RA, etc..). I could even argue that sales de-value a Biotech company because it gives investors something to tack value to instead of the exciting nature of a future drug.

So - let's see some sales, but if these guys can get a Phase II started in MS we could really something.